Latest Breaking News On - Robertj fox - Page 5 : comparemela.com

EQS-News: Immunic to Participate in Scientific and Investor Conferences in June

Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Scientific and Investor Conferences in June 30.05.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate in Scientific and Investor Conferences in June NEW YORK,.

United statesAurora hallEdna kaplanPaula schwartzRobertj foxJessica breuDistribution servicesNeurologic instituteExchange commissionConsortium of multiple sclerosis centersImmunic incMellen centerRx communications groupInternational conventionInvestor conferencesMultiple sclerosis centers

EQS-News: Immunic, Inc : Immunic to Participate in Scientific and Investor Conferences in June

Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Scientific and Investor Conferences in June 30.05.2023 / 12:30 CET/CEST The issuer is solely responsible

United statesRobertj foxEdna kaplanAurora hallJessica breuPaula schwartzInternational conventionNeurologic instituteExchange commissionConsortium of multiple sclerosis centersImmunic incDistribution servicesMellen centerRx communications groupInvestor conferencesMultiple sclerosis centers

Small cap snapshot: Soma Gold, Thor Explorations, Revolve Renewable Power, PyroGenesis, Numinus

Small cap snapshot: Soma Gold, Thor Explorations, Revolve Renewable Power, PyroGenesis, Numinus
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesRobertj foxSteve hansonRobert kaulLithium incRakovina therapeutics incInternational conventionMetals corpRogers creek property to cascade copper corpImmunic incKillum wynn creative incMaxim groupConsortium of multiple sclerosis centersLiam greenlawWynn creative

Immunic, Inc Reports First Quarter 2023 Financial Results and Provides Corporate Update

– Positive Results From Phase 1b Clinical Trial of IMU-856 in Celiac Disease Provide Proof-of-Concept for a New Therapeutic Approach to Treat Gastrointestinal.

United statesRichard rudickJosepha murrayPaula schwartzEdna kaplanRobertj foxJessica breuVincent ossipowMichael schumannDaniel vittAmericas committee for treatmentRx communications groupExchange commissionMellen centerDevelopment rd expensesImmunic inc

Immunic : Q1 2023 News Release | MarketScreener

Immunic, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Update Positive Results From Phase 1b Clinical. | May 11, 2023

United statesEdna kaplanVincent ossipowRichard rudickJessica breuJosepha murrayPaula schwartzMichael schumannDaniel vittRobertj foxNeurologic instituteImmunic incAmericas committee for treatmentExchange commissionRx communications groupMellen center